China Dom. Bio-tech Hldgs Inc. (fka CDBH)

[Potse]

Fuzhou project, other items.....

"CCKH is a complete POS. 1 for 46 reverse split? Maggot factory? You must be seriously deranged if you think any institutional investor is ever go to buy a maggot-selling POS like this. If I were you I would dump my shares at 10 cents and be happy to be out of this thing."

My understanding (based on news snippets and items on government websites, see links below) is that the Fuzhou project (the "maggot factory") is expected to be completed and commissioned this year.

Relevant information regarding the project.....

1) 300 acres
2) 180 new jobs
3) $31M -- total cost of the project
4) $221M annual revenue capability
5) $47M annual net income capability (assuming 25% tax rate)

If I am correct in believing/assuming that the RM will have an initial 10M or less outstanding share structure, $20M financing at $5 or higher, and Belmont retaining 1M shares or less, the fully diluted share count should be in the 15-20M area (including warrants).

Based on the revenue/income potential and the nature of the current and potential markets/products, my hunch is that Daqing Morinaga probably is not going to have difficulty attracting institutional investments over time. And with the low float, my hunch is that with a little patience I will have opportunities to sell at a profit rather than take a loss (my average price is under 26 cents -- under $12 post-split).

But that is just my opinion/viewpoint, not shared by many others.

Reference to the 180 new jobs, completion date, etc......

Evening News on January 15, materials Pharmaceutical Co., Ltd. Fuzhou Sheng Yongsheng Lin Chuanqu ask the North Industrial Park in the foundation-stone laying ceremony was held. The company is specialized in the housefly insect activity of protein in the field of applied biological technology research and development, production and sales of high-tech bio-pharmaceutical company, Total investment 210 million yuan, covering an area of 300 acres. A project completed and commissioned at the end of this year, after completion of the project can realize annual output value of 1.5 billion, profits and taxes 80 million yuan, 180 new jobs.

http://tinyurl.com/2ckw8jf

The following is from a government website that lists/describes projects in the province where the Fuzhou project is located. This item is of interest because it was listed in the section of projects in Fuzhou that have actually started construction, which basically confirms that the project is in fact real and underway. The link below will take you directly to the specific item of interest, rather than having to scroll through the various projects.....

March 4, by the U.S. NASDAQ listed company in China holding company, housefly biological industry in Fushun investment in the North Industrial Park, Fuzhou Sheng Yongsheng material Pharmaceuticals housefly biotransformation protein, bio-pharmaceutical projects started, a total investment of 210 million yuan. After completion of the project is expected to be realized main business income of 1.5 billion, tax 80 million yuan.

http://tinyurl.com/2dxezwt

Medical products/devices: If you go back to post #189, there is a item that mentions Daqing Morinaga's products/technologies in a broad sense: "clinical nutrition protein, non-medical nutrition protein, skin care products, drugs, burns four major categories of 15 varieties of products".

I don't know whether the medical device types of products are currently in the company's commercial offerings or whether they are still working through the pipeline but clearly the company has been working on things beyond just the nutrition/cosmetics side of the business.

The following is from a word document that I found some time ago, located on an educational institute's website. The link to the actual document no longer functions, but I was able to find another source. If I recall correctly the date on the original document was 2006, but it is possible this is from sometime between 2006-2008. Basically this was an item about a research project that Daqing Morinaga was doing to take a more microbial approach to the extraction/production of chitin......

As the marine coastal zone of the large area of industrial pollution, bringing the quality of chitin severely affected, very difficult to develop Medical grade products. Insects are rich in chitin, through artificial cultivation of the control environment and the extraction of science can be consistent with the requirements of medical and food products of high purity chitin.
The project purified insect chitin product covering pharmaceuticals, pharmaceutical intermediates, aerospace and military field first-aid field, has developed sophisticated technology, including: biological surgical sutures, artificial skin, surgical dressing, battlefield first aid bandages to stop bleeding, biological fungicide, biological preservatives.

http://tinyurl.com/2bm8fb7

Crone Law Group: Although there is nothing in the SEC filings to verify this, it is highly likely that The Crone Law Group (Mark Crone) will be the legal representative for the RM. Crone has been representing many of the recent Belmont China reverse mergers, and the firm reserved the "China Domestica Bio-Technology Holdings" name. Crone would likely handle all of the legal matters related to the SEC and the $20M financing......

http://tinyurl.com/22ocv4y